Equities

Evolent Health Inc

Evolent Health Inc

Actions
  • Price (EUR)15.10
  • Today's Change-7.90 / -34.35%
  • Shares traded--
  • 1 Year change-42.80%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 07:52 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Evolent Health, Inc. is a health care company connecting care for people with complex conditions like cancer, cardiovascular disease, and musculoskeletal diagnoses. The Company offers three primary solutions: specialty care management services, total cost of care management and administrative services. It provides comprehensive quality management for oncology and cardiology patients from diagnosis through advance care planning services as well as identifying quality, lowest cost of care for outpatient orthopedic surgeries. Its total cost of care management solution enables providers to manage populations they may be accountable for under value-based contracts with payers or accountable care organizations (ACO) contracts with Centers for Medicare and Medicaid Services (CMS). Its administrative services solution includes integrated value-based care platform designed to help customers manage and administer patient health in a cost-effective manner.

  • Revenue in USD (TTM)2.35bn
  • Net income in USD-106.20m
  • Incorporated2014
  • Employees4.70k
  • Location
    Evolent Health Inc800 N Glebe Rd Ste 500ARLINGTON 22203-2151United StatesUSA
  • Phone+1 (571) 389-6000
  • Fax+1 (571) 389-6001
  • Websitehttps://www.evolenthealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.